Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Mechanisms Underlying Adrenal Dysfunction in Cirrhosis and Its Prognostic Significance

NCT04642391 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04642391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Mechanisms Underlying Adrenal Dysfunction in Cirrhosis and Its Prognostic Significance
Lead sponsor
University of Virginia
Phase
Observational
Overall status
Completed
Start date
August 2, 2021
Completion date
June 30, 2024
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal insufficiency, cirrhosis